Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 2/20 | 0.45 |
| ▸ | CA1 | P00915 | 2/20 | 0.45 |
| ▸ | CA9 | Q16790 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | STAT3 | P40763 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | PSMD10 | O75832 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA3 | P07451 | 1/20 | 0.38 |
| ▸ | CA6 | P23280 | 1/20 | 0.38 |
| ▸ | CA5A | P35218 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19003422 | 1.00 | ALDH1A1 (0.47) | ALDH1A1LMNAHPGDHTTCA12 | |
| SCHEMBL18998977 | 1.00 | ALDH1A1 (0.47) | ALDH1A1LMNAHPGDHTTCA12 | |
| SCHEMBL2329512 | 1.00 | ALDH1A1 (0.47) | ALDH1A1LMNAHPGDHTTCA12 | |
| SCHEMBL1218220 | 1.00 | ALDH1A1 (0.47) | ALDH1A1LMNAHPGDHTTCA12 | |
| SCHEMBL361530 | 1.00 | ALDH1A1 (0.47) | ALDH1A1LMNAHPGDHTTCA12 | |
| SCHEMBL25398474 | 1.00 | ALDH1A1 (0.47) | ALDH1A1LMNAHPGDHTTCA12 | |
| SCHEMBL8282614 | 1.00 | ALDH1A1 (0.47) | ALDH1A1LMNAHPGDHTTCA12 | |
| SCHEMBL22262524 | 1.00 | ALDH1A1 (0.47) | ALDH1A1LMNAHPGDHTTCA12 | |
| SCHEMBL21877144 | 1.00 | ALDH1A1 (0.47) | ALDH1A1LMNAHPGDHTTCA12 | |
| SCHEMBL13169282 | 1.00 | ALDH1A1 (0.47) | ALDH1A1LMNAHPGDHTTCA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 565 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113248352-B | Method for synthesizing heptaglyme through solid phase | 长沙创新药物工业技术研究院有限公司 | 2024-08-13 | — | — | CN | claimed |
| CN-117327299-A | Graphene oxide-based temperature-sensitive composite hydrogel and preparation method and application thereof | 同济大学 | 2024-01-02 | — | — | CN | claimed |
| CN-116891476-A | Fluorescent probe for rapidly detecting hydrogen sulfide gas and preparation method and application thereof | 云南电力试验研究院(集团)有限公司 | 2023-10-17 | — | — | CN | claimed |
| CN-112174785-B | Fluorescent probe based on tetraphenylethylene derivative, preparation method and application thereof | 扬州大学 | 2022-03-29 | — | — | CN | claimed |
| CN-113248352-A | Method for solid-phase synthesis of heptaethylene glycol monomethyl ether | 湖南华腾制药有限公司 | 2021-08-13 | — | — | CN | claimed |
| CN-112174785-A | Fluorescent probe based on tetraphenylethylene derivative, preparation method and application thereof | 扬州大学 | 2021-01-05 | — | — | CN | claimed |
| EP-3524638-B1 | AMINOSILANE-BASED COMPOUND, PROCESS FOR PREPARING SAME, AND MODIFIED CONJUGATED DIENE-BASED POLYMER COMPRISING SAME | LG CHEMICAL LTD (KR) | 2020-06-17 | — | — | EP | claimed |
| CN-110734450-A | hydrogen sulfide fluorescent probes and preparation method and application thereof | 贺州学院 | 2020-01-31 | — | — | CN | claimed |
| CN-104177393-A | Photosensitizer, and preparation method and application thereof | SHENZHEN CHINA RESOURCES GOSUN PHARMACEUTICAL CO LTD | 2014-12-03 | — | — | CN | claimed |
| US-20260077069-A1 | COMBINATIONS OF CONTRAST AGENTS | BAYER AG (DE) | 2026-03-19 | — | — | US | disclosed |
| EP-4692071-A1 | PHOTOCHROMIC COMPOUND, NAPHTHOL DERIVATIVE, CURABLE COMPOSITION, OPTICAL ARTICLE, LENS, AND EYEGLASS | TOKUYAMA CORPORATION (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-12540278-B2 | Temperature programmable small molecules for thermoresponsive smart windows and applications thereof | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2026-02-03 | — | — | US | disclosed |
| US-12508251-B2 | CD4 mimic compound with anti-HIV activity | NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY; (JP) | 2025-12-30 | — | — | US | disclosed |
| US-20250313572-A1 | MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE | ABBVIE INC (US) | 2025-10-09 | — | — | US | disclosed |
| WO-1993020078-A1 | PHARMACEUTICALLY ACTIVE BICYCLIC-HETEROCYCLIC AMINES | THE UPJOHN COMPANY (US) | 1993-10-14 | — | — | WO | disclosed |
| WO-1993009088-A1 | IMPROVED METHOD FOR SYNTHESIS OF DESFERRIOXAMINE B, ANALOGS AND HOMOLOGS THEREOF | UNIVERSITY OF FLORIDA (US) | 1993-05-13 | — | — | WO | disclosed |
| EP-0519996-A1 | IMIDAZOLES | RHONE-POULENC RORER LIMITED (GB) | 1992-12-30 | — | — | EP | disclosed |
| WO-1991013876-A1 | IMIDAZOLES | RHONE-POULENC RORER LIMITED (GB) | 1991-09-19 | — | — | WO | disclosed |
| EP-0337714-A2 | HIV protease inhibitors useful for the treatment of aids | MERCK & CO. INC. (US) | 1989-10-18 | — | — | EP | disclosed |
| US-4436664-A | PHASE TRANSFER AGENTS | W. R. GRACE & CO. (US) | 1984-03-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260077069-A1 | COMBINATIONS OF CONTRAST AGENTS | GBA1, GBA3, GLS2 | ALDH1A1 3682/4885LMNA 431/4885HPGD 1941/4885 |
| US-12508251-B2 | CD4 mimic compound with anti-HIV activity | CD4, CD81, SLC11A2 | ALDH1A1 1615/4885LMNA 4562/4885HPGD 3528/4885 |
| US-20250313572-A1 | MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE | MCL1, BCL2A1, BCL2L10 | ALDH1A1 641/4885LMNA 420/4885HPGD 4461/4885 |
| US-12540278-B2 | Temperature programmable small molecules for thermoresponsive smart windows and applications thereof | CRY1, C1S, CRY2 | ALDH1A1 309/4885LMNA 946/4885HPGD 3480/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.